Jiangsu Bioperfectus Technologies Co., Ltd. (688399.SS)
- Previous Close
69.53 - Open
70.00 - Bid 69.59 x --
- Ask 69.60 x --
- Day's Range
68.88 - 70.88 - 52 Week Range
57.32 - 105.15 - Volume
284,779 - Avg. Volume
722,405 - Market Cap (intraday)
3.944B - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.48 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date May 30, 2022
- 1y Target Est
--
Jiangsu Bioperfectus Technologies Co., Ltd., a molecular diagnostic company, engages in the research, development, production, and sale of in vitro diagnostic products in China. It offers in vitro diagnostic reagents and supporting testing equipment, as well as in vitro testing services. The company was founded in 2010 and is headquartered in Taizhou, China.
www.s-sbio.comRecent News: 688399.SS
View MorePerformance Overview: 688399.SS
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 688399.SS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 688399.SS
View MoreValuation Measures
Market Cap
3.94B
Enterprise Value
2.36B
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
13.10
Price/Book (mrq)
1.21
Enterprise Value/Revenue
6.75
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-8.35%
Return on Assets (ttm)
-1.59%
Return on Equity (ttm)
-0.87%
Revenue (ttm)
350.1M
Net Income Avi to Common (ttm)
-29.25M
Diluted EPS (ttm)
-0.48
Balance Sheet and Cash Flow
Total Cash (mrq)
1.96B
Total Debt/Equity (mrq)
11.58%
Levered Free Cash Flow (ttm)
4.88M